Clinical utility gene card for: Hypophosphatasia-update 2013

European Journal of Human Genetics

Volumn 22, Issue 4, 2014, Pages

  Mornet, Etienne ^a,b   Hofmann, Christine ^c   Bloch Zupan, Agnès ^d,e,f   Girschick, Hermann ^g   Le Merrer, Martine ^h  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b CENTRE HOSPITALIER DE VERSAILLES   (France)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^g VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; GENE MUTATION; GENETIC SCREENING; HUMAN; HYPOPHOSPHATASIA; INCIDENCE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; GENETICS; GENOTYPE; PHENOTYPE;

ALKALINE PHOSPHATASE; ALPL PROTEIN, HUMAN;

ALKALINE PHOSPHATASE; GENETIC TESTING; GENOTYPE; HUMANS; HYPOPHOSPHATASIA; PHENOTYPE;

EID: 84896542151     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.177     Document Type: Article

References (42)

1. Zurutuza L, Muller F, Gibrat JF et al: Correlations of genotype and phenotype in hypophosphatasia. Hum Mol Genet 1999; 8: 1039-1046
2. Muller HL, Yamazaki M, Michigami T et al: Asp361Val Mutant of alkaline phosphatase found in patients with dominantly inherited hypophosphatasia inhibits the activity of the wild-Type enzyme. J Clin Endocrinol Metab 2000; 85: 743-747
3. Lia-Baldini AS, Brun-Heath I, Carrion C et al: A new mechanism of dominance in hypophosphatasia: The mutated protein can disturb the cell localisation of the wildtype protein. Hum Genet 2008; 123: 429-432
4. Lia-Baldini AS, Muller F, Taillandier A et al: A molecular approach to dominance in hypophosphatasia. Hum Genet 2001; 109: 99-108
5. Fauvert D, Brun-Heath I, Lia-Baldini AS et al: Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet 2009; 10: 51
6. Whyte MP, Teitelbaum SL, Murphy WA, Bergfeld MA, Avioli LV: Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore) 1979; 58: 329-347
7. Eberle F, Hartenfels S, Pralle H, Kabisch A: Adult hypophosphatasia without apparent skeletal disease: 'odontohypophosphatasia' in four heterozygote members of a family. Klin Wochenschr 1984; 62: 371-376
8. Eastman JR, Bixler D: Clinical, laboratory, and genetic investigations of hypophosphatasia: Support for autosomal dominant inheritance with homozygous lethality. J Craniofac Genet Dev Biol 1983; 3: 213-234
9. Spentchian M, Brun-Heath I, Taillandier A et al: Characterisation of missense mutations and large deletions in the ALPL gene by sequencing and quantitative multiplex PCR of short fragments. Genet Test 2006; 10: 252-257
10. Fraser D: Hypophosphatasia. Am J Med 1957; 22: 730-746
11. Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B: A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 2011; 75: 439-445
12. Greenberg CR, Evans JA, McKendry-Smith S et al: Infantile hypophosphatasia: Localisation within chromosome region 1p36.1-34 and prenatal diagnosis using linked DNA markers. Am J Hum Genet 1990; 46: 286-292
13. Whyte MP, Essmyer K, Geimer M, Mumm S: Homozygosity for TNSALP mutation 1348c4T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. J Pediatr 2006; 148: 753-758
14. Pauli RM, Modaff P, Sipes SL, Whyte MP: Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: Bent but not broken. Am J Med Genet 1999; 86: 434-438
15. Moore CA, Curry CJ, Henthorn PS et al: Mild autosomal dominant hypophosphatasia: In utero presentation in two families. Am J Med Genet 1999; 86: 410-415
16. Wenkert D, McAlister WH, Coburn SP et al: Hypophosphatasia: Nonlethal disease despite skeletal presentation in utero (17 new cases and literature review). J Bone Miner Res 2011; 26: 2389-2398
17. Reibel A, Maniere MC, Clauss F et al: Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. Orphanet J Rare Dis 2009; 4: 6
18. Whyte MP, Wenkert D, McAlister WH et al: Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia. J Bone Miner Res 2009; 24: 1493-1505
19. Deeb AA, Bruce SN, Morris AA, Cheetham TD: Infantile hypophosphatasia: Disappointing results of treatment. Acta Paediatr 2000; 89: 730-733
20. Sutton RA, Mumm S, Coburn SP, Ericson KL, Whyte MP: 'Atypical femoral fractures' during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 2012; 27: 987-994
21. Whyte MP, Mumm S, Deal C: Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 2007; 92: 1203-1208
22. Camacho PM, Painter S, Kadanoff R: Treatment of adult hypophosphatasia with teriparatide. Endocr Pract 2008; 14: 204-208
23. Gagnon C, Sims NA, Mumm S et al: Lack of sustained response to teriparatide in a patient with adult hypophosphatasia. J Clin Endocrinol Metab 2010; 95: 1007-1012
24. Schalin-Jantti C, Mornet E, Lamminen A, Valimaki MJ: Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. J Clin Endocrinol Metab 2010; 95: 5174-5179
25. Girschick HJ, Seyberth HW, Huppertz HI: Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatory drugs. Bone 1999; 25: 603-607
26. Girschick HJ, Schneider P, Haubitz I et al: Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet J Rare Dis 2006; 1: 24
27. Millan JL, Narisawa S, Lemire I et al: Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 2008; 23: 777-787
28. Whyte MP, Greenberg CR, Salman NJ et al: Enzyme-replacement therapy in lifethreatening hypophosphatasia. N Engl J Med 2012; 366: 904-913
29. Sugano H, Matsumoto T, Miyake K et al: Successful gene therapy in utero for lethal murine hypophosphatasia. Hum Gene Ther 2012; 23: 399-406
30. Baumgartner-Sigl S, Haberlandt E, Mumm S et al: Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T4C, p.M226T; c.1112C4T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 2007; 40: 1655-1661
31. Balasubramaniam S, Bowling F, Carpenter K et al: Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5'- phosphate availability. J Inherit Metab Dis 2010; doi:10.1007/s10545-009-9012-y.
32. Hofmann C, Liese J, Schwarz T et al: Compound heterozygosity of two functional null mutations in the ALPL gene associated with deleterious neurological outcome in an infant with hypophosphatasia. Bone 2013; 55: 150-157
33. Girschick HJ, Haubitz I, Hiort O, Schneider P: Long-Term follow-up of bone mineral density in childhood hypophosphatasia. Joint Bone Spine 2007; 74: 263-269
34. Girschick HJ, Mornet E, Beer M, Warmuth-Metz M, Schneider P: Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy. BMC Pediatr 2007; 7: 3
35. Wolfish NM, Heick H: Hyperparathyroidism and infantile hypophosphatasia: Effect of prednisone and vitamin K therapy. J Pediatr 1979; 95: 1079-1081
36. Whyte MP: Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 2010; 1192: 190-200
37. Moulin P, Vaysse F, Bieth E et al: Hypophosphatasia may lead to bone fragility: Don't miss it. Eur J Pediatr 2009; 168: 783-788
38. Collmann H, Mornet E, Gattenlohner S, Beck C, Girschick H: Neurosurgical aspects of childhood hypophosphatasia. Childs Nerv Syst 2009; 25: 217-223
39. Lynch CD, Ziada HM, Buckley LA, O'Sullivan VR, Aherne T, Aherne S: Prosthodontic rehabilitation of hypophosphatasia using dental implants: A review of the literature and two case reports. J Oral Rehabil 2009; 36: 462-468
40. Whyte MP: Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994; 15: 439-461
41. Stevenson DA, Carey JC, Coburn SP et al: Autosomal recessive hypophosphatasia manifesting in utero with long bone deformity but showing spontaneous postnatal improvement. J Clin Endocrinol Metab 2008; 93: 3443-3448
42. Sinico M, Levaillant JM, Vergnaud A et al: Specific osseous spurs in a lethal form of hypophosphatasia correlated with 3D prenatal ultrasonographic images. Prenat Diagn 2007; 27: 222-227